In the third quarter of 2021, the Asia Pacific region achieved revenue of CHF 105 million, an organic sales growth of 29% compared to the same period in 2020. Patient flow in most countries is strong. Due to the ongoing pandemic-related restrictions, travel opportunities are still limited. This leads to higher disposable income that local consumers can spend on oral health. China, Japan and Australia are driving growth in this region, with strong contributions from premium implants and digital solutions. The Group introduced biomaterials in China for the first time in October, while also launching Anthogyr in South Korea and announcing a direct presence in Malaysia.

Latin America growth supported by good patient flow and market share gains

Performance in Latin America during the third quarter of 2021 was significantly better than in the same quarter of 2020, which heavily suffered from the pandemic as Latin America was affected later than other regions. Revenue increased by 63% to CHF 38 million. Patient flow is good and the Group continues to gain market share in this region. This trend is being led by Brazil, which is the Group's largest revenue contributor in Latin America, followed by Mexico and Chile. While presently representing a comparatively small part of the overall revenue in the region, the orthodontics business is expanding very rapidly. Neodent remains the Group's strongest brand in Latin America, while the premium implant brands and digital solutions are performing very well, with the Virtuo Vivo intraoral scanner successfully established.

OUTLOOK 2021 RAISED (BARRING UNFORESEEN CIRCUMSTANCES)

Dental practices were operating with healthy patient flows throughout the first nine months of 2021. The Group's offerings of innovative solutions and strong execution drove growth in the third quarter and led to continued market share gains. Pandemic-related restrictions have impacted consumer behavior by limiting spending alternatives such as traveling, leaving some consumers with more disposable income to spend on specialty dental treatments. This trend can be expected to gradually soften as spending opportunities will further open up. Consequently, the Group raises its guidance to full-year organic revenue growth in the high-thirties percentage range, with profitability at least at the 2019 level.

About Straumann Group

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs more than 8000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland

Phone: +41 (0)61 965 11 11

Homepage: www.straumann-group.com

Contacts: 


Corporate Communication 
Silvia Dobry: +41 (0)61 965 15 62           Investor Relations 
Jana Erdmann: +41 (0)61 965 12 39           Marcel Kellerhals: +41 (0)61 965 17 51 E-mail: 
                                            investor.relations@straumann.com 
E-mail: 
corporate.communication@straumann.com

ANALYSTS' AND MEDIA CONFERENCE CALL

Straumann will present its 2021 third-quarter results to representatives of the financial community and media in a webcast telephone conference call today at 10.30 am Swiss time.

The webcast can be accessed via www.straumann-group.com/webcast. A replay of the webcast will be available after the conference.

If you intend to ask a question during the Q&A, we kindly ask you to pre-register for the conference call through this link 'Conference call' . We also recommend that you download the presentation file in advance using the direct link in this media release before joining the conference call.

Presentation

The conference presentation slides are attached to this release and available on the Media and Investors pages at www.straumann-group.com.

UPCOMING CORPORATE / INVESTOR EVENTS 


Date          Event                                     Location 
2021 
November 4    ZKB Swiss Equity Conference               Zurich 
November 8    UBS European Conference                   Virtual 
November 17   Credit Suisse Equity Forum Switzerland    Zurich 
November 22   Exane BNP Paribas MedTech CEO Conference  Virtual 
November 23   JP Morgan North America Roadshow          Virtual 
December 7    Credit Suisse European Bus Tour           Virtual 
December 16   Capital Markets Day                       Hybrid 
2022 
February 15   Full-year results                         Webcast

Disclaimer

This release contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this release. The Group is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise.

-----------------------------------------------------------------------------------------------------------------------

End of ad hoc announcement

----------------------------------------------------------------------------------------------------------------------- 


Language:     English 
Company:      Straumann Holding AG 
              Peter Merian-Weg 12 
              4052 Basel 
              Switzerland 
Phone:        +41619651239 
Fax:          +41 61 965 11 06 
E-mail:       jana.erdmann@straumann.com 
Internet:     www.straumann-group.com 
ISIN:         CH0012280076 
Valor:        914326 
Listed:       SIX Swiss Exchange 
EQS News ID:  1244188 
 
End of Announcement EQS Group News Service 
=------------

1244188 28-Oct-2021 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1244188&application_name=news

(END) Dow Jones Newswires

October 28, 2021 00:31 ET (04:31 GMT)